HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Mark Brown Selected Research

KT182

10/2018Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Mark Brown Research Topics

Disease

20Obesity
03/2024 - 10/2003
17Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 08/2006
17Atherosclerosis
01/2019 - 10/2003
16Inflammation (Inflammations)
12/2023 - 09/2008
14Insulin Resistance
01/2023 - 10/2003
12Fibrosis (Cirrhosis)
03/2024 - 04/2016
12Neoplasms (Cancer)
11/2023 - 10/2003
10Non-alcoholic Fatty Liver Disease
04/2024 - 05/2010
7Liver Diseases (Liver Disease)
12/2023 - 07/2020
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 09/2008
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 03/2006
5Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2016
5Metabolic Diseases (Metabolic Disease)
10/2020 - 04/2013
4Glioblastoma (Glioblastoma Multiforme)
11/2023 - 07/2014
4Body Weight (Weight, Body)
01/2019 - 05/2009
3Hepatitis
11/2023 - 01/2017
3Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2020
3Fatty Liver
07/2021 - 12/2015
3Hyperlipidemias (Hyperlipidemia)
01/2020 - 09/2008
3Thrombosis (Thrombus)
01/2019 - 03/2016
3Weight Gain
01/2019 - 11/2010
3Chanarin-Dorfman Syndrome
01/2013 - 10/2007
3Hypercholesterolemia
06/2012 - 08/2006
2Demyelinating Diseases (Demyelinating Disease)
11/2018 - 10/2018
2Disease Progression
10/2018 - 01/2018
2Stroke (Strokes)
03/2016 - 05/2013
2Myocardial Infarction
03/2016 - 05/2013
2Hypersensitivity (Allergy)
10/2009 - 09/2008
1Pathologic Constriction (Stenosis)
03/2024
1Ischemic Stroke
11/2023
1Brain Diseases (Brain Disorder)
11/2023
1Rupture
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1Abdominal Aortic Aneurysm
01/2023
1Hyperinsulinism (Hyperinsulinemia)
01/2023
1Aneurysm (Aneurysms)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
12/2022

Drug/Important Bio-Agent (IBA)

18LipidsIBA
04/2024 - 08/2008
17trimethyloxamine (trimethylamine N-oxide)IBA
11/2023 - 05/2013
12CholesterolIBA
01/2019 - 03/2006
11Antisense OligonucleotidesIBA
09/2023 - 08/2006
10EnzymesIBA
11/2023 - 04/2013
8dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA
01/2023 - 01/2015
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2010
7Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2014
6AcyltransferasesIBA
09/2023 - 08/2006
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2024 - 01/2019
5RNA (Ribonucleic Acid)IBA
12/2023 - 01/2021
5Insulin (Novolin)FDA Link
01/2023 - 02/2012
5Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 09/2008
5LDL Receptors (LDL Receptor)IBA
01/2019 - 08/2006
5HydrolasesIBA
11/2018 - 10/2013
4Proteins (Proteins, Gene)FDA Link
03/2024 - 04/2013
4CytokinesIBA
03/2024 - 11/2005
4trimethylamineIBA
10/2023 - 05/2013
4Bile Acids and Salts (Bile Acids)IBA
01/2021 - 01/2017
4Triglycerides (Triacylglycerol)IBA
01/2015 - 10/2007
3Choline (Choline Chloride)IBA
01/2023 - 03/2016
3Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 01/2017
3Hormones (Hormone)IBA
04/2022 - 01/2015
3Volatile Fatty AcidsIBA
01/2022 - 01/2018
3DiglyceridesIBA
01/2016 - 11/2010
3LDL CholesterolIBA
01/2014 - 03/2009
3Conjugated Linoleic AcidsIBA
04/2013 - 10/2003
3Lipoproteins (Lipoprotein)IBA
09/2008 - 08/2006
2LigandsIBA
03/2024 - 09/2023
2Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
12/2023 - 08/2023
2Docosahexaenoic AcidsIBA
12/2023 - 08/2023
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2023 - 08/2023
2Tyrosine (L-Tyrosine)FDA Link
11/2023 - 04/2016
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2022 - 01/2020
2Succinic Acid (Succinate)IBA
01/2022 - 01/2022
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
07/2021 - 01/2021
2HDL LipoproteinsIBA
12/2020 - 07/2015
2Scavenger Receptors (Scavenger Receptor)IBA
12/2020 - 07/2014
2Phosphotransferases (Kinase)IBA
10/2020 - 11/2017
2EndocannabinoidsIBA
11/2018 - 12/2015
2Carnitine (L-Carnitine)FDA LinkGeneric
04/2016 - 05/2013
2Lipase (Acid Lipase)FDA Link
12/2014 - 08/2014
2Sterol O-Acyltransferase 2IBA
10/2014 - 08/2006
2Dietary CholesterolIBA
06/2012 - 05/2010
2stearoyl-coenzyme A (stearoyl-CoA)IBA
06/2010 - 09/2008
2Apolipoprotein B-100 (Apo B 100)IBA
05/2010 - 09/2008
2Stearoyl-CoA DesaturaseIBA
01/2010 - 10/2009
2Toll-Like Receptor 4IBA
10/2009 - 09/2008
2Sterol O-AcyltransferaseIBA
04/2008 - 08/2006
1lysophosphatidylinositolIBA
04/2024
1SpermidineIBA
11/2023
1PolyaminesIBA
11/2023
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
11/2023
1Aromatic Amino Acids (Aromatic Amino Acid)IBA
11/2023
1Tryptophan (L-Tryptophan)FDA Link
11/2023
1IsotopesIBA
11/2023
1LactoferrinIBA
10/2023
1Macrophage Migration-Inhibitory FactorsIBA
10/2023
1Sucrose (Saccharose)IBA
01/2023
1fluoromethylcholineIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
12/2022

Therapy/Procedure

13Therapeutics
03/2024 - 01/2010
2Drug Therapy (Chemotherapy)
12/2022 - 07/2021